Health Canada is expected to announce Monday it has approved Pfizer’s Paxlovid antiviral pill for use in the fight against COVID-19. Global News has learned the agency has given regulatory authorization for the pill.

Last month, the federal government announced it signed a purchase agreement with Pfizer to buy up to one million courses of its treatment, pending regulatory approval.

Pfizer began a rolling submission with Health Canada in December for Paxlovid, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply.

The pill has also been approved for use in the United States by the U.S. Food and Drug Administration.

For more info, please go to https://globalnews.ca/news/8516373/pfizers-paxlovid-covid-antiviral-pill-approved-canada/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #COVID19 #Paxlovid